INTRODUCTION
Macromolecular biopolymers, nanometer-sized materials, and bacteriophage offer unique opportunities for advances in bioimaging and medicine (Boisselier and Astruc, 2009; Ghosh et al., 2012; Leader et al., 2008; McGregor, 2008; Thorek et al., 2006) . Perhaps the most important impediment to their broader use is the difficulties associated with the potent delivery of these reagents across the lipid bilayer membrane of mammalian cells (Torchilin and Lukyanov, 2003) . Various technologies have been developed that address challenges in the delivery of large cargos to mammalian cells. These generally include liposomes (Gregoriadis, 1995) , lipid-linked compounds (Zelphati et al., 2001 ), fusions to cell-surface receptor ligands (Gabel and Foster, 1986; Rizk et al., 2009) , and supercharged proteins (Cronican et al., 2010 (Cronican et al., , 2011 McNaughton et al., 2009) .
One promising approach for the delivery of macroscopic cargo to mammalian cells is attachment with a protein transduction domain (PTD). PTDs are short peptides (typically <20 amino acids) that promote the internalization of cargo in mammalian cells (Deshayes et al., 2005; Ford et al., 2001; Mä e and Langel, 2006) . Although PTDs promote general transmembrane transport, virtually every strategy to identify and combat disease can be improved by selective delivery of cargo specifically to diseased cells. The most common method for targeting cargo to a specific cell is through fusion to a monoclonal antibody or its fragment antigen-binding region (Fab fragment), which binds a receptor present on the targeted cell. Although such immunoconjugate-targeted therapies are often cell-selective, they do not directly address the problem of cell internalization. Further, their production, distribution, and storage are very costly (Hughes, 2010; Wu and Senter, 2005) . Unfortunately, commercially available and commonly used polycationic PTDs, such as the HIV-1 transactivator of transcription (Tat) peptide (Frankel and Pabo, 1988; Green and Loewenstein, 1988) , the Drosophila Antennapedia-derived penetratin peptide (Derossi et al., 1994) , and polyarginine (Dubikovskaya et al., 2008; Fuchs and Raines, 2005) , although simple to use, do not selectively penetrate diseased cells, and their potency of uptake is relatively moderate to poor.
An ideal delivery platform would combine the cell selectivity of antibodies with the membrane transport capability and ease of production of PTDs. As part of a broader research program focused on new methods to identify (image) and treat prostate cancers, we set out to generate a prostate cancer cell-selective PTD. The prostate-specific membrane antigen (PSMA) is a membrane-bound glycoprotein that is restricted to the prostate. Previously, studies analyzing the expression of PSMA have found an upregulation in correlation with prostate cancer Lapidus et al., 2000) . Unsurprisingly, targeted delivery of cargo to prostate cancer cells often relies on antibodies, Fab fragments (Henry et al., 2004; Nanus et al., 2003; Patri et al., 2004) , or other ligands, such as aptamers (Dassie et al., 2009) , that bind PSMA. However, the expression level of PSMA varies drastically among prostate cancer cells, and many prostate cancer cells do not express PSMA Wright et al., 1995) . Therefore, in addition to targeted delivery platforms, which extend beyond the antibody paradigm, reagents that selectively target PSMA-negative prostate cancer cells are required.
Bacteriophage (phage) evolution has been used to identify PTDs not found in nature (Gao et al., 2002; Ivanenkov et al., 1999; Kim et al., 2006; Nomura et al., 2007) . We began by performing consecutive rounds of positive selections to enrich phage that penetrate PC-3 cells, a human prostate cancer cell line with high metastatic potential (Pulukuri et al., 2005 ) that does not express significant levels of PSMA (PSMA-neg) (Ghosh et al., 2005) , and remove phage that do not penetrate the four offtarget cell lines described below. After three rounds of positive and negative selection, only phage with modest potency of uptake and very poor cell selectivity were enriched. Changing the order of the selection (positive to negative or negative to positive) did not change the outcome. One possible reason for this undesired outcome is the selection strategy itself. In this scheme, ''winners'' may be phage with poor uptake efficiencies in both targeted and untargeted cells. This phage would be expected to barely survive both the positive and negative selection.
Based on our initial results, we modified the positive and negative selection to enrich for phage that potently penetrate targeted PC-3 cells and remove polycationic PTD, which should not be cell selective. From this selection, we identified phage that display five copies of a linear 12-amino-acid peptide on the N terminus of phage minor coat protein 3 (p3). This peptide is referred to as ''Ypep'' (N-YTFGLKTSFNVQ-C) throughout. Our data show that multivalency effects dramatically tune the potency and, perhaps more importantly, the cell selectivity of Ypep uptake. When cells are treated with a solution containing 5 mM GFP equipped with a single N-terminal Ypep peptide (Ypep-GFP), $4-, $5-, and $8-fold more Ypep-GFP penetrate targeted PC-3 cells than off-target LNCaP (PSMA-positive prostate cancer [Israeli et al., 1994] ), Hs 697.Sp (human spleen) cells, and HEK293T (human embryonic kidney), respectively. We observe $40% more GFP in targeted PC-3 cells following treatment with 5 mM Ypep-GFP, compared to off-target MRC-9 human lung cells. The N termini and C termini of folded GFP are proximal and are therefore spatially arranged in such a way as to facilitate multivalent interactions between the termini of GFP and a receptor, making this protein well suited to examine the role multivalency effects play in uptake. When Ypep is fused to the N termini and C termini of GFP (Ypep-GFP-Ypep), the potency of GFP delivery increased $29-fold in targeted PC-3 cells. Perhaps more importantly, multivalency effects also control the cell selectivity of cell penetration. The cell selectivity profiles of Ypep-GFP and Ypep-GFP-Ypep for targeted PC-3 cells over off-target LNCaP, HEK293T, and Hs 697.Sp cells were similar. However, $3.8-fold more Ypep-GFP-Ypep penetrated PC-3 cells than off-target MRC-9 cells. GFP bearing two 5 -phage penetrate PC-3 cells in the presence of human blood. Collectively, our findings reveal Ypep as a PTD with cell selectivity and potency profiles that are tightly controlled by multivalency effects. Our results may have broader application in the use of (Ypep) 5 -phage as a cell-targeted delivery vehicle, as well as the design of PTD-based technologies that are generated using phage display evolution.
RESULTS AND DISCUSSION
Phage Display In Vitro Evolution of a Protein Transduction Domain Platform Targeting PC-3 Prostate Cancer Cells As summarized in Figure 1 , the selection involved incubating the phage library with a monolayer of PC-3 prostate cancer cells. In order to assure that only internalized phage were selected and enriched, as opposed to phage that simply bound to the surface of PC-3 cells, an extensive washing protocol was developed from components of numerous literature reports (Gao et al., 2002; Ivanenkov et al., 1999; Kim et al., 2006) . Media containing phage without affinity for PC-3 cells was removed, and the cells were washed five times with PBS and then three times with Trisbuffered saline (TBS)/0.1% Tween-20 solution. Cells were then treated with a solution containing 3 mg/ml subtillisin in TBS for 40 min at 4 C, which removed any remaining cell-surface-bound phage by proteolytic degradation of the phage coat proteins and/or human cell surface proteins involved in the phagecell interaction. Following the subtillisin treatment, cells were washed three times with PBS containing a protease inhibitor cocktail and pelleted by centrifugation. Titering from the final PBS wash solution after subtillisin treatment showed that no cell-surface-bound phage were present, indicating that the washing scheme removed all phage that did not penetrate the
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Multivalency Effects Control Cell Uptake cells (Supplemental Experimental Procedures). Cells were then lysed with a solution previously shown to lyse human cells, but not phage (Ivanenkov et al., 1999) . Phage present in cell lysate was amplified in Escherichia coli.
In order to remove phage that contain polycationic PTDs, which would likely penetrate cells nonselectively, or phage that simply bind the tissue culture plate, phage enriched from the positive selection were incubated for 1 hr with a vacuum-gas plasma-treated tissue culture plate, which contains a monolayer of carboxylic acids on the tissue culture plate surface and is therefore negatively charged at physiological pH. Only phage remaining in the solution, and not bound to the culture plate surface, were enriched. Coupled rounds of positive and negative selections were performed three times. After the final negative selection round, enriched phage were amplified in E. coli and grown as single plaques on an agar plate. Single plaques were isolated and grown in Luria Broth (LB), and phage was isolated and precipitated using standard methods. The sequence of evolved PTDs was identified using standard DNA sequencing methods. The most abundant sequence enriched from this selection was ''Ypep'' (N-YTFGLKTSFNVQ-C); little sequence homology was observed among the evolved peptide sequences. Among these enriched peptides, Ypep was determined to be the most cell-selective and potent PTD.
Determining the Potency of Ypep-GFP Uptake
We prepared a fusion protein consisting of an N-terminal Ypep sequence, a (GGS) 4 linker, and super-folder GFP (sfGFP). This fusion protein is referred to as ''Ypep-GFP'' throughout. In many ways, GFP is an ideal protein to test the characteristics of a PTD. For example, GFP is simple to express, is stable, and is easy to image (Tsien, 1998) . Although obviously not of human origin, the molecular weight (27 kDa) and net theoretical charge at physiological pH (À6) of GFP are within the average range among human proteins expressed in E. coli (Cronican et al., 2011) . Like most proteins, wild-type GFP does not penetrate human cells (Supplemental Experimental Procedures). Finally, GFP and its variants, or proteins with similar biophysical characteristics, have been used for various in vitro and in vivo bioimaging applications (Filonov et al., 2011; Shaner et al., 2004) .
PC-3 cells were treated with 0.5, 1, 5, or 10 mM Ypep-GFP. Following treatment, this solution was removed, and the cells were washed with a solution previously shown to remove surface-bound protein (Cronican et al., 2010 (Cronican et al., , 2011 McNaughton et al., 2009; Meade and Dowdy, 2008) , trypsinized, and assayed for internalized Ypep-GFP by cytometry. As shown in Figure 2A , we observed a concentration-dependent increase in Ypep-GFP levels in PC-3 prostate cancer cells. Flow cytometry data were collected in three separate experiments; $42-and $86-fold more cell fluorescence is observed in cells following treatment with 5 or 10 mM Ypep-GFP, respectively. Fluorescence microscopy images show internalized Ypep-GFP in PC-3 cells following treatment with 10 mM Ypep-GFP ( Figure 2B ). In contrast, no appreciable fluorescence was observed in cells treated with 10 mM GFP, then washed, and imaged using the same conditions (Supplemental Experimental Procedures). Taken together, these data validate the PTD selection.
Determining the Effect Multivalency Has on the Potency of Ypep-Dependent Delivery
Although we were pleased to observe that a single copy of Ypep delivers GFP to PC-3 prostate cancer cells, we were somewhat surprised by the modest potency of cellular uptake. We reasoned that because selections involve phage, which present Ypep on the N terminus of five separate copies of phage minor coat protein 3, multivalent display might be needed in order to fully realize highly potent Ypep-dependent delivery. Multivalency effects play critical roles in numerous biological processes (D) Fluorescence microscopy image of PC-3 cells after a 1 hr treatment with 10 mM Ypep-GFP-Ypep and subsequent washing with PBS containing 20 U/ml heparin sulfate. All images were taken using a 500 ms exposure. Lamp intensity was set at 20% for all images. See also Figures S2, S3, S5, and S8. (Mammen et al., 1998) and have been shown to contribute to the mechanism of uptake for a previously reported PTD (Moss et al., 2005) . The N termini and C termini of GFP are in close proximity and have similar directionality (Supplemental Experimental Procedures). Therefore, GFP is well suited to serve as a protein scaffold and test the dependency of multivalent effects on uptake. Toward this end, we prepared a fusion protein with Ypep on the N termini and C termini of GFP (Ypep-GFP-Ypep).
PC-3 cells were treated with solutions containing 0.1-10 mM Ypep-GFP-Ypep, were washed with a solution shown to remove cell-surface-bound protein, were trypsinized from the tissue culture plate, and internalized GFP levels were measured in three separate experiments by flow cytometry. As shown in Figure 2C , we observed a concentration-dependent increase in Ypep-GFPYpep delivery in PC-3 cells, with a dramatic increase in the potency of uptake. This large difference in uptake potency was confirmed by comparing microscopy images of cells treated with 10 mM Ypep-GFP ( Figure 2B measure if this observation is universal among commonly used and commercial PTDs. We prepared GFP fusion proteins that contain either a single N-terminal fusion with Tat or penetratin PTDs (referred to as Tat-GFP and Pen-GFP, respectively). In addition, we prepared GFP fusion proteins that contain N-and C-terminal Tat or penetratin (referred to as Tat-GFP-Tat and Pen-GFP-Pen, respectively). Like Ypep-GFP and Ypep-GFPYpep fusion proteins, in each case, Tat or penetratin is separated from GFP through a (GGS) 4 linker. Polyarginine is a commonly used PTD (Dubikovskaya et al., 2008) ; unfortunately, all attempts to express and purify (Arg) 9 -GFP and (Arg) 9 -GFP-(Arg) 9 failed.
PC-3 cells were treated with solutions containing 5 mM Ypep-GFP, Tat-GFP, or Pen-GFP. This concentration was chosen because it was the lowest concentration that resulted in relatively high levels of Ypep-GFP delivery. After such time, cells were washed three times with a PBS solution containing 20 U/ml heparin sulfate to remove any cell-surface-bound protein. Cells were trypsinized from the tissue culture plate, and GFP fluorescence was measured by flow cytometry. As seen in Figure 3A , treatment with this concentration of fusion protein resulted in the delivery of comparatively high levels of Ypep-GFP and Pen-GFP to PC-3 cells. In contrast, appreciable levels of Tat-GFP did not penetrate PC-3 cells at the concentration tested. Next, we incubated PC-3 cells with solutions containing 100 nM Ypep-GFP-Ypep, Tat-GFP-Tat, or Pen-GFP-Pen. This concentration was chosen because it was the lowest concentration that resulted in relatively high levels of Ypep-GFP-Ypep delivery. As shown in Figure 3B , although bivalent display of Ypep resulted in a $20-fold increase in GFP delivery, the same effect was not observed for Pen-GFP-Pen and Tat-GFP-Tat fusions. In contrast to Ypep-GFP-Ypep, bivalent display of penetratin does not increase uptake. Previous reports have shown that 4-5 copies of Tat and as many as 10-50 copies of penetratin are required for a significant increase in the potency of uptake, compared to the potency of delivery observed for a monomeric fusion (Tseng et al., 2002) . In addition, multivalent dendrimer-PTD conjugates have been reported to increase potency of uptake compared to a monovalent species (Li et al., 2009; Sung et al., 2006) . However, these species typically contain >20 copies of the PTD per dendrimer. In contrast, we observe a dramatic increase in the potency of delivery for GFP fusions containing two copies of Ypep. Taken together, these data show the unique role multivalency plays on the potency of Ypep-dependent delivery of GFP.
Determining the Cell Selectivity of Ypep-Dependent Delivery Given the role multivalency plays in the potency of Ypep-dependent delivery, we hypothesized that those same effects may contribute to the cell selectivity of uptake. We compared the delivery of Ypep-GFP, Ypep-GFP-Ypep, (Ypep) 2 -GFP, and (Ypep) 5 -phage in PC-3 human prostate cancer cells (PSMA-neg), LNCaP human prostate cancer cells (PSMA-pos), HEK293T human embryonic kidney cells, MRC-9 human lung fibroblast cells, and Hs 697.Sp human spleen fibroblast cells. The potency and cell selectivity of Ypep-GFP and Ypep-GFP-Ypep delivery was measured by flow cytometry. Phage titering from cell lysate was used to compare the amount of internalized phage in each cell line.
Cell Selectivity of Ypep-GFP Delivery Cells were treated with solutions containing 0.5-5 mM Ypep-GFP and then washed three times with a PBS solution containing 20 U/ml heparin sulfate to remove any cell-surface-bound protein. After removal from the tissue culture plate, internalized GFP levels were measured by flow cytometry.
As shown in Figure 4 , a single copy of Ypep endows appreciable selectivity of delivery. Following treatment with 5 mM Ypep-GFP, we observed $4-, $8-, and $5-fold more internalized GFP in targeted PC-3 cells compared to off-target LNCaP, HEK293T, and Hs 687.Sp cells. High levels of internalized GFP were found in off-target MRC-9 cells; only $1.4-fold more fluorescence was observed in targeted PC-3 cells. Taken together, these data demonstrate that monomeric Ypep is moderately selective for PC-3 cells.
Cell Selectivity of Ypep-GFP-Ypep Delivery
We compared cell penetration of Ypep-GFP-Ypep in PC-3, LNCaP, HEK293T, MRC-9, and Hs 697.Sp cells. Cells were treated with solutions containing 0.1-5 mM Ypep-GFP-Ypep and then washed three times with a PBS solution containing 20 U/ml heparin sulfate to remove any cell-surface-bound protein. Cells were trypsinized from the tissue culture plate, and cell fluorescence was measured by flow cytometry.
As shown in Figure 5 , we observed higher levels of cell selectivity for Ypep-GFP-Ypep delivery in targeted PC-3 cells, compared to monomeric Ypep-GFP. Like Ypep-GFP, Ypep-GFP-Ypep was taken up by targeted PC-3 cells, and much lower levels of internalized GFP was observed in off-target LNCaP, HEK293T, and Hs 697.Sp cells. However, unlike Ypep-GFP, which was taken up well in both targeted PC-3 and off-target MRC-9 cells, Ypep-GFP-Ypep showed a $4-fold preference for PC-3 cells over MRC-9 cells. Taken together, these data demonstrate an important role for multivalency in the cell selectivity of delivery.
Cell Selectivity of (Ypep) 5 -Phage Delivery We tested the selectivity of (Ypep) 5 -phage delivery in PC-3, LNCaP, HEK293, MRC-9, and Hs 697.Sp cells by comparing the titer of phage from lysate of each cell after incubation and washing steps. Cells were treated with 5 ml of F12K/10% FBS containing 1.0 3 10 9 plaque-forming units (pfu)/ml of (Ypep) 5 -phage. This equates to a solution that is 1.7 pM in phage. Thus, cell penetration at this concentration indicates very high potency. After incubating the phage with cells, cell-surface-bound phage was removed, and cells were lysed as described previously. In addition to titering cell lysate, aliquots from each final washing solution were titered to ensure that all surface-bound phage was removed before cell lysis. No phage was found in any of the final washing solution (Supplemental Experimental Procedures). In contrast, (Ypep) 5 -phage potently penetrate PC-3 prostate cancer cells (PSMA-neg); high levels of (Ypep) 5 -phage plaque-forming units per milliliter (pfu/ml) were found from PC-3 cell lysate. However, appreciable levels of (Ypep) 5 -phage plaques were not observed from the lysate of LNCaP (PSMApos), HEK293T (kidney), Hs 697.Sp (spleen), and MRC-9 (lung) cells ( Figure 6 ). Experiments were independently performed in triplicate. Appreciable levels (>25 pfu/ml) of phage were never observed in E. coli treated with cell lysate from LNCaP (PSMApos), HEK293T (kidney), Hs 697.Sp (spleen), or MRC-9 (lung) cells. In contrast, in each experiment >1,500 pfu/ml were observed in E. coli treated with PC-3 cell lysate. Although appreciable, but significantly lower, levels of Ypep-GFP and Ypep-GFP-Ypep were found in off-target LNCaP and MRC-9 cells, and much lower levels of (Ypep) 5 -phage were not found in the lysate of these off-target cells, compared to targeted PC-3 cells. This represents a dramatic change in the cell selectivity of Ypepdependent delivery. Although these data suggest that multivalency effects likely play a role in the cell selectivity of uptake, the architecture of Ypep display in the context of fusion to GFP and fusion to the N terminus of phage coat protein p3 differ greatly. We cannot rule out the possibility that these architectural changes may play an important role in the cell selectivity profiles we observe. Nonetheless, the cell selectivity and potency profiles displayed by bivalent Ypep-GFP fusions and (Ypep) 5 -phage make Ypep well suited for targeted bioimaging applications, as well as phage-based approaches to biomedical science.
Determining the Mechanism of Ypep-GFP, Ypep-GFPYpep, and (Ypep) 5 -Phage Internalization
The majority of known PTDs have high positive net charge. In contrast, Ypep has a theoretical net charge of +1. In addition, we have shown that Ypep displays interesting multivalencydependent behavior. Given the characteristics of Ypep, we were very interested in establishing the mechanism of internalization for Ypep-GFP, Ypep-GFP-Ypep, and (Ypep) 5 -phage.
Unlike experiments conducted at 37 C, cell penetration was not observed when PC-3 cells were cooled to 4 C before and during treatment with either 15 mM of Ypep-GFP or 10 mM Ypep-GFP-Ypep ( Figures 7B and 7H, respectively) . These results suggest that cell penetration of Ypep-GFP and Ypep-GFP-Ypep requires an energy-dependent process, consistent with endocytosis (Meade and Dowdy, 2008) . We next evaluated the cell penetration of each Ypep variant under conditions that block a particular component of an endocytotic pathway. PC-3 cells were incubated with relatively high concentrations of Ypep-GFP or Ypep-GFP-Ypep to assure that changes in cell fluorescence were due to inhibition of cell penetration as opposed to relatively small changes in uptake of low concentrations of GFP fusions that may or may not be associated with inhibition of endocytosis. When PC-3 cells were pretreated with PBS containing 5 mg/ml filipin, a small molecule known to inhibit lipidraft/caveolae-dependent endocytosis (Schnitzer et al., 1994) , and then incubated with a solution containing 5 mg/ml filipin and either Ypep-GFP or Ypep-GFP-Ypep, much lower cell fluorescence was observed compared to cells that were not treated with the inhibitor molecule ( Figures 7C and 7I, respectively) . In addition, pretreating cells with 5 mg/ml cytochalasin D, an actin polymerization inhibitor (May et al., 1998) , followed by incubating those cells with 5 mg/ml cytochalasin D and either Ypep-GFP or Ypep-GFP-Ypep significantly decreased cell penetration (Figures 7D and 7J, respectively) . In contrast, similar treatment with 10 mg/ml chlorpromazine, an inhibitor of clathrin-mediated endocytosis (Wang et al., 1993) , had little effect on the efficiency of cell penetration for both Ypep-GFP and Ypep-GFP-Ypep ( Figures 7E and 7K , respectively). Internalization of caveolae requires disruption of the local actin cytoskeleton (Head et al., 2006; Shen and Turner, 2005) . Therefore, inhibition of cell penetration as a result of lipid-raft/caveolae-dependent endocytosis and actin polymerization supports the conclusion that Ypep-GFP and Ypep-GFP-Ypep penetration of PC-3 cells is mediated by lipid-raft/caveolae-dependent endocytosis. Internalization of Ypep-GFP and Ypep-GFP-Ypep is inhibited by 400 mg/ml heparin sulfate ( Figures 7F and 7L, respectively) . Based on previous studies (De Coupade et al., 2005; Mano et al., 2005) , this suggests that internalization requires interaction(s) with one or more glycosaminoglycans on the surface of PC-3 cells.
We next applied the conditions shown in Figure 7 , and described above, to PC-3 cells treated with (Ypep) 5 -phage. Unlike Ypep-GFP and Ypep-GFP fusions, which can be removed using a relatively simple washing procedure, and for which internalized protein can be immediately imaged, experiments with phage require a relatively substantial and lengthy washing procedure in order to assure that all phage are removed from the cell surface and only internalized phage are isolated. Unfortunately, following treatment with filipin, cytochalasin D, and chloropromazine, PC-3 cells did not withstand the washing protocol. We observed significant loss of cells throughout the experiment due to cytotoxicity. Therefore, we were unable to obtain meaningful data from those experiments. Because of this, studies on the mechanism of (Ypep) 5 -phage penetration in PC-3 cells were limited to conditions that were not cytotoxic to the cells during the course of the experiments.
Unlike experiments conducted at 37 C, which yielded high levels of phage from cell lysate, no phage were isolated when PC-3 cells were cooled to 4 C before and during treatment with (Ypep) 5 -phage. This result suggests that cell penetration of (Ypep) 5 -phage requires an energy-dependent process, consistent with endocytosis (McNaughton et al., 2009; Meade and Dowdy, 2008) . In addition, internalization of (Ypep) 5 -phage was inhibited by heparin sulfate (Supplemental Experimental Procedures), suggesting that internalization requires interaction(s) with one or more glycosaminoglycans on the surface of PC-3 cells. The ability to significantly decrease or completely abrogate the levels of Ypep-GFP, Ypep-GFP-Ypep, and (Ypep) 5 -phage by suppressing particular endocytotic pathways further supports The number of plaque-forming units/ml found in each cell lysate is provided above each bar. See also Figures S4, S5 , and S8. the conclusion that these protein fusions are internalized under normal conditions, which lack modulators of endocytosis.
Determining the Cytotoxicity and Robustness of Ypep-Dependent Delivery
To assess the cytotoxicity of Ypep variants under conditions required for appreciable uptake, we performed (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay (MTT) on PC-3 cells after treatment with 0.5, 1, or 5 mM Ypep-GFP or Ypep-GFP-Ypep, or 1.7 pM (Ypep) 5 -phage. These assays revealed no apparent cytotoxicity to PC-3 cells for any of the Ypep variants (Supplemental Experimental Procedures).
Phage selections were performed in a complex solution consisting of F12K cell culture media and 10% fetal bovine serum (FBS). In order for a PTD to be used in vivo, it must penetrate the target cell in the presence of a complex solution, such as blood. We treated PC-3 cells with either 10 mM Ypep-GFP or Ypep-GFP-Ypep in F12K/10% FBS solution containing 50% human blood. Cells were then washed as described, and red blood cells were removed using standard methods. Cell fluorescence was measured by flow cytometry. Ypep-GFP-Ypep, but not Ypep-GFP, penetrates PC-3 cells in a solution containing human blood. In addition, when PC-3 cells were treated with 1.7 pM (Ypep) 5 -phage in a F12K/10% FBS solution containing 50% human blood, appreciable levels of phage were found in cell lysate (Supplemental Experimental Procedures). Taken together, these data suggest that multivalent Ypep-dependent cell penetration is functional in blood. The extreme potency of (Ypep) 5 -phage cell penetration is not abrogated in the presence of human blood.
In conclusion, using phage evolution, we identified a PTD (Ypep) whose potency and selectivity for targeted PC-3 prostate cancer cells is tightly controlled through multivalency. When a single copy of Ypep is attached to the N terminus of GFP (Ypep-GFP), this fusion protein penetrates a diverse set of human cells with modest potency and poor cell selectivity. When Ypep is attached to the N termini and C termini of GFP (Ypep-GFP-Ypep), potency increases $9-to 29-fold over the same set of human cells, and cell selectivity increases. Although the same approximate level of Ypep-GFP is found in PC-3 (PSMA-neg) and MRC-9, $4-fold more Ypep-GFP-Ypep is found in PC-3 cells over a range of concentrations. However, phage that display five copies of Ypep ((Ypep) 5 -phage) very potently and selectively penetrate PC-3 cells. When a diverse set of human cells are treated with media containing 10% FBS solution that is 1.7 pM in (Ypep) 5 -phage, these phage penetrate PC-3 cells, but not LNCaP (prostate cancer, PSMA-pos), HEK293T (kidney), Hs 697.Sp (spleen), and MRC-9 (lung) cells. Collectively, our results reveal Ypep as a PTD capable of delivering protein (GFP) or nanometer-sized cargo (phage), with cell-penetrating properties that are tightly controlled through multivalency effects. Both Ypep-GFP-Ypep and (Ypep) 5 -phage penetrate cells in the presence of human blood. All Ypep-dependent cell penetration is non-cytotoxic at conditions required for uptake and proceeds via endocytosis. Both Ypep-GFP and Ypep-GFP-Ypep penetrate PC-3 cells through caveolae/lipid-raft-mediated endocytosis.
We anticipate that (Ypep) 5 -phage may be useful as a potent and robust platform for the targeted delivery of cargo to prostate cancer tumors bearing PC-3 cells. (Ypep) 5 -phage can be genetically engineered to display biopolymer imaging reagents and/or therapies on various phage coat proteins (p7, p8, and/or p9). Although functional therapeutic delivery will require release of phage from endosomes, phage can also be engineered to orthogonally display endosomolytic peptides, which have been shown to facilitate the disruption of endosomes from within various cells (Han et al., 2011; Lundberg et al., 2007; Meyer et al., 2008; Oishi et al., 2007) . In addition, given that we observed no obvious change in the mechanism of internalization for each Ypep variant, identifying the cell surface receptor(s) for Ypep-GFP, Ypep-GFPYpep, and (Ypep) 5 -phage on PC-3 cells, as well as the sequence dependence on cellular uptake, will be important for understanding the basis of changes in cell selectivity and uptake potencies. Progress toward this end will be reported in due course.
SIGNIFICANCE
Protein transduction domains (PTDs) offer a straightforward method for the delivery of biopolymer and nanoscale reagents to the interior of mammalian cells. Although functionally simple, most PTDs promote general transmembrane transport and are not cell selective. Cell-selective recognition is typically achieved through the use of antibody-based immunoconjugates; however, these reagents are relatively difficult and expensive to prepare and do not directly address the problem of internalization. In this work, we identified a PTD with uptake, cell selectivity, and potency profiles that are tightly controlled through multivalency effects. We have shown that single attachment of Ypep to GFP promotes uptake of that fusion protein, with relatively modest cell selectivity and potency. Double fusion of Ypep to the N termini and C termini of GFP increased the potency of uptake for that fusion protein to levels beyond those explained by simple additive effects, suggesting a role for multivalency in cell uptake of Ypep variants. These bivalent displaydependent changes in potency and cell selectivity demonstrated by Ypep were not observed with Tat or penetratin protein fusions. Phage that display five copies of Ypep on the N terminus of p3 penetrate targeted PC-3 prostate cancer cells with potency and cell selectivity profiles that meet or exceed those typically associated with antibodies and antibody fragments. Collectively, our results reveal Ypep as a PTD with tunable potency and cell selectivity profiles and establish (Ypep) 5 -phage as an extremely potent and cellselective PTD platform capable of delivering an imaging reagent protein (GFP) and nanoscale reagents (phage) to a malignant prostate cancer cell line that is not susceptible to PSMA-targeted prostate-cancer-targeted therapeutic delivery platforms. Our investigations reported in this paper are a starting point for the optimization of genetically engineered (Ypep) 5 -phage for use in PC-3 cell-targeted biopolymer and nanoscale therapeutic and imaging delivery. for 3 min each while on ice. The remaining surface-bound phage was proteolyzed by addition of a 5 ml TBS/subtilisin (3 mg/ml) for 45 min at 4 C. Cells were then transferred into a 15 ml plastic tube and pelleted for 5 min at 3,000 rpm and at 4 C. Supernatant was removed, and cells were resuspended in 5 ml PBS/5 ml protease inhibitor for 15 min at 4 C and then pelleted for 5 min at 3,000 rpm and 4 C. Supernatant was removed, and cells were resuspended in 1 ml of PBS and pelleted for 5 min at 3,000 rpm and 4 C.
Supernatant was removed and saved as the last wash solution for subsequent titering. Cells were lysed with 0.5 ml of lysis buffer (2% sodium deoxycholate, 10 mM Tris-HCl, and 2 mM EDTA) and 0.5 ml of TBS for 1 hr at room temperature. After cell lysis, internalized phage was amplified in a 150 ml flask containing 30 ml LB, 360 ml 0.1 M CaCl 2 , 20 mg/ml tetracycline, and 0.15 ml of E. coli (ER2837) that had been grown to optical density (OD) z0.5. The final wash solution (200 ml) or the cell lysate was then added, and this solution was incubated at 37 C, 250 rpm for 5 hr. E. coli was pelleted for 10 min at 10,000 rpm and 4 C. Supernatant containing phage was transferred to another tube, and E. coli cell debris was pelleted at 10,000 rpm for 10 min at 4 C. Phage from the supernatant was precipitated by addition of 5 ml 20% PEG-8000/2.5 M NaCl. Phage was only amplified after positive selection rounds; the phage-containing media from negative selections was directly added to positive cell lines without amplification of the phage. Negative selection: A 10 ml solution containing 10 9 pfu/ml amplified from the positive selection was added to a T25 culture flask and incubated at 37 C with 5% CO 2 environment for 1 hr. Rounds of positive and negative selection were performed three times.
Chemistry & Biology
Multivalency Effects Control Cell Uptake
Plasmid Contruction
All constructs were cloned into pET plasmids. DNAs encoding cell-penetrating peptide fusions with sfGFP were assembled using oligonucleotide overlap gene construction and PCR.
Protein Purification BL21-DE3 E. coli were typically grown in 500 ml LB cultures at 37 C to OD 600 z0.6 and induced with 1 mM IPTG at 30 C overnight. Cells were then pelleted by centrifugation and lysed with 25 ml B-PER. Cell lysate was cleared by centrifugation (17,000 rpm, 30 min), and supernatant was mixed with 1 ml of Ni-NTA agarose resin for 1 hr at 4 C under agitation. Resin was collected by centrifugation (4,950 rpm, 10 min). Ni-NTA agarose resin was washed with 50 ml of PBS containing 300 mM NaCl and then 50 ml of PBS containing 20 mM imidazole. Protein was then eluted with 5 ml PBS containing 300 mM NaCl and 500 mM imidazole. Eluted protein was dialyzed against PBS and analyzed for purity by SDS-PAGE followed by staining with Coomassie Blue. Protein concentrations were measured using a modified Lowry Protein Assay Kit.
Flow Cytometry
Mammalian cells were grown to $80% confluency in a 6-well plate. Cells were washed once with PBS and PBS containing Ypep-GFP, (Ypep) 2 -GFP, or Ypep-GFP-Ypep was added. Cells were incubated with each PBS/protein solution for 3 hr at 37 C under 5% CO 2 environment and then washed twice with PBS and three times with PBS-HS (heparin sulfate 20 U/ml) for 10 min each at 37 C. Cells were then removed from the tissue culture plate by addition of 0.5 ml of 0.25% trypsin and pelleted by centrifugation. Cell pellet was resuspended in PBS/10% FBS, and cell fluorescence was analyzed by flow cytometry.
Mechanism of Cell Penetration
PC-3 cells were grown to $80% confluency in a 12-well tissue culture plate. Cells were then washed once with PBS and incubated with the small molecule inhibitor in PBS for 10 min at 37 C under 5% CO 2 environment. The PBSsmall-molecule solution was then removed, and a PBS solution containing either 15 mM Ypep-GFP or 10 mM Ypep-GFP-Ypep with a small molecule inhibitor in PBS was added to the cells. Cells were incubated in each solution for 30 min at 37 C under 5% CO 2 environment. Cells were washed twice with PBS, once with PBS-HS (heparin sulfate 20 U/ml), and imaged on an EVOS fl fluorescence microscope.
Cell Selectivity Experiments
For experiments involving Ypep-GFP and Ypep-GFP-Ypep, cell penetration was measured using flow cytometry, as described above (see Flow Cytometry). For cell selectivity experiments involving (Ypep) 5 -phage, cells were grown to $80% confluency and then treated with 5 ml of media supplemented with 10% FBS and 1 3 10 9 pfu/ml (Ypep) 5 -phage for 3 hr at 37 C and 5% CO 2 environment. Cells were washed and lysed as previously described (see Phage Selection). An aliquot of the final wash solution was kept for titering. Following cell lysis (see Phage Selection), aliquots from cell lysate and the last wash before lysis were titered. Titering was carried out as described above (see Phage Selection). After this time, the entire E. coli mixture was plated on IPTG/X-gal LB-agar plates and incubated at 37 C for 18 hr.
MTT Cell Viability Assay
Assays were performed following the provided instructions. Briefly, PC-3 cells were grown to $80% confluency in a 12-well tissue culture plate. Cells were then washed once with PBS and incubated with 0.5-5 mM Ypep-GFP or Ypep-GFP-Ypep in PBS for 3 hr at 37 C under a 5% CO 2 environment. Cells were washed three times with PBS-HS (20 U/ml heparin sulfate) and then incubated with 0.5 ml media containing 25 ml of MTT reagent for 4.5 hr. After such time, a 250 ml detergent reagent was added to the cells, and they were incubated for an additional 30 min at 37 C under a 5% CO 2 environment.
Absorbance was measured at 570 nm on a Synergy Mx microplate reader. Cell viability of cells treated with (Ypep) 5 -phage was determined after a 3 hr incubation with 5 ml of 1 3 10 9 pfu/ml Ypep-phage (1.67 pM) in F12K medium supplemented with 10% FBS at 37 C under a 5% CO 2 environment. PC-3 cells were washed twice with PBS, and the MTT assay was performed as described above.
Ypep-GFP and Ypep-GFP-Ypep Internalization in the Presence of Human Blood PC-3 cells were grown to $80% confluency in a 6-well plate. Whole blood was diluted in half with F12K/10% FBS. To this solution either Ypep-GFP or Ypep-GFP-Ypep was added to final concentrations of 10 mM. Cells were incubated with these solutions for 1 hr, washed once with PBS, and then washed twice with a red blood cell lysis buffer (0.15 M NH 4 Cl, 0.01 M KHCO 3 , and 0.0001 M EDTA [pH = 7.7] ) to remove all red blood cells. Cells were washed three times with PBS-HS (20 U/ml heparin sulfate) and imaged on an EVOS fl fluorescence microscope.
(Ypep) 5 -Phage Internalization in the Presence of Human Blood PC-3 cells were grown to $80% confluency in a 6-well plate. Whole blood was diluted in half with F12K/10% FBS. To this solution, 1 3 10 9 (Ypep) 5 -phage (1.67 pM) was added. Cells were incubated in this solution for 3 hr at 37 C under a 5% CO 2 environment. Cells were washed twice with red blood cell lysis buffer, twice with PBS, and three times with Tris-buffered saline (TBS)/ 0.1% v/v Tween-20 for 3 min each on ice. Cells were then washed as described. Aliquots from final wash and cell lysate solutions were titered as described previously (see Phage Selection: Positive Selection). 
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